AR019981A1 - Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida. - Google Patents

Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida.

Info

Publication number
AR019981A1
AR019981A1 ARP990103817A ARP990103817A AR019981A1 AR 019981 A1 AR019981 A1 AR 019981A1 AR P990103817 A ARP990103817 A AR P990103817A AR P990103817 A ARP990103817 A AR P990103817A AR 019981 A1 AR019981 A1 AR 019981A1
Authority
AR
Argentina
Prior art keywords
solid
pharmaceutical composition
prepare
procedure
dosage form
Prior art date
Application number
ARP990103817A
Other languages
English (en)
Spanish (es)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of AR019981A1 publication Critical patent/AR019981A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP990103817A 1998-08-01 1999-07-30 Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida. AR019981A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9816723.2A GB9816723D0 (en) 1998-08-01 1998-08-01 Therapeutic agents

Publications (1)

Publication Number Publication Date
AR019981A1 true AR019981A1 (es) 2002-03-27

Family

ID=10836508

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103817A AR019981A1 (es) 1998-08-01 1999-07-30 Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida.

Country Status (16)

Country Link
EP (1) EP1100471B1 (enExample)
JP (1) JP2002522376A (enExample)
CN (1) CN1160060C (enExample)
AR (1) AR019981A1 (enExample)
AT (1) ATE249815T1 (enExample)
AU (1) AU744483B2 (enExample)
CA (1) CA2339190C (enExample)
DE (1) DE69911427T2 (enExample)
DK (1) DK1100471T3 (enExample)
ES (1) ES2207274T3 (enExample)
GB (1) GB9816723D0 (enExample)
MX (1) MXPA01000992A (enExample)
NZ (1) NZ509593A (enExample)
PT (1) PT1100471E (enExample)
WO (1) WO2000007569A1 (enExample)
ZA (1) ZA200100828B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030034171A (ko) 2001-07-06 2003-05-01 엔도 파마슈티걸즈, 인크. 옥시모르폰 제어 방출 제형
WO2003026743A2 (en) * 2001-09-26 2003-04-03 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
CN117752805B (zh) * 2023-12-25 2024-12-24 山东聊城阿华制药股份有限公司 一种药用辅料及其制备方法
KR102881485B1 (ko) * 2024-03-22 2025-11-05 (주) 팜젠사이언스 천연첨가제에 기반한 비타민c 조성물 및 이를 포함하는 지속성 비타민c 정제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135979A (en) * 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
EP0399774A1 (en) * 1989-05-24 1990-11-28 Merck & Co. Inc. Composition and method for rheology controlled printing of fabric and carpet

Also Published As

Publication number Publication date
CN1354653A (zh) 2002-06-19
WO2000007569A1 (en) 2000-02-17
CN1160060C (zh) 2004-08-04
EP1100471B1 (en) 2003-09-17
NZ509593A (en) 2002-12-20
CA2339190C (en) 2008-11-18
ATE249815T1 (de) 2003-10-15
ES2207274T3 (es) 2004-05-16
AU744483B2 (en) 2002-02-28
ZA200100828B (en) 2001-10-22
EP1100471A1 (en) 2001-05-23
JP2002522376A (ja) 2002-07-23
PT1100471E (pt) 2003-12-31
CA2339190A1 (en) 2000-02-17
DE69911427T2 (de) 2004-07-01
DE69911427D1 (de) 2003-10-23
MXPA01000992A (es) 2002-06-04
AU5508799A (en) 2000-02-28
DK1100471T3 (da) 2004-01-12
GB9816723D0 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
AR080436A2 (es) Preparacion solida de desintegracion rapida, uso de una hidroxipropilcelulosa poco sustituida en dicha preparcion y metodo para mejorar la desintegrabilidad oral de la misma
AR059324A2 (es) Una forma solida de dosificacion oral
AR036700A1 (es) Forma de dosificacion oral solida de simeticona
AR042937A2 (es) Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento
ES2181055T3 (es) Formulaciones galenicas que contienen antagonistas de opiaceos.
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
ES2584183T3 (es) Formulaciones de cladribina para suministro mejorado oral y transmucosa
CO4340618A1 (es) Composicion farmaceutica para liberacion controlada
AR040722A1 (es) Formulaciones y formas de dosificacion para la administracion controlada de topiramato
MXPA05007643A (es) Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo.
PE20060075A1 (es) Composiciones farmaceuticas de alisciren
HUP0000141A2 (hu) Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására
BRPI0410116A (pt) tablete de cuidado oral
AR018607A1 (es) Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion
ECSP034826A (es) Método para fabricar una composición farmacéutica de dosis baja
BR0307278A (pt) Formulação oral de liberação imediata, e, método para preparar uma formulação
CO4940406A1 (es) Composiciones de paracetamol de accion rapida
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
AP2003002763A0 (en) Controlled release formulations for oral administration
BR0214497A (pt) Composição farmacêutica que compreende um agonista do receptor 5ht1
DE60221227D1 (de) Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen
AR045719A1 (es) Formulacion farmaceutica que comprende levotiroxina sodica, celulosa microcristalina y almidon pregelatinizado; uso de la misma para la fabricacion de un medicamento y proceso para preparar dicha formulacion
CL2004001843A1 (es) Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax

Legal Events

Date Code Title Description
FB Suspension of granting procedure